Search
Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.
The global clinical research community is facing a clear imperative to move beyond traditional manual data management methods in order to improve data capture, integrity, and exchange, while pursuing other related efficiencies.
Vivian Strong, MD, FACS, the Iris Cantor Chair, addressed colleagues and gastric cancer experts from around the world at the International Gastric Cancer Congress 2022.
Zvi Fuks has been elected a member of the Institute of Medicine, one of the highest honors in the fields of health and medicine.
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
A new imaging approach relying on Cerenkov light could sometimes substitute for PET scans and improve diagnostic services in underserved areas.
Andrew L. Kung, MD, PhD, has been named the new Chairman of the Department of Pediatrics at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician, researcher, leader, and mentor, Dr. Kung most recently served as the Chief of the Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation at New York-Presbyterian/Morgan Stanley Children’s Hospital and Columbia University Medical Center (CUMC). Dr. Kung formally assumes his new role as Richard J. O’Reilly, MD, steps down as Chairman after more than 30 years.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
Campaign — inspired by Matthew Heineman’s new documentary, ‘American Symphony,’ featuring Jon Batiste and Suleika Jaouad — aims to bridge the blood stem cell and marrow donor gap and give hope to patients in need.